Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Coxiella burnetii RSA 493

ABSTRACT: Nine Mile phase I isolate that causes Q fever

PROVIDER: PRJNA41 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR9493370.fastq.gz	Fastqsanger.gz
	SRR9493371.fastq.gz	Fastqsanger.gz
	SRR9493372.fastq.gz	Fastqsanger.gz
	SRR9493373.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 7

Similar Datasets

Coxiella burnetii RSA 331

Project description:Northern Italy isolate that causes Q fever

| PRJNA16791 | ENA

Coxiella Burnetii

Project description:Coxiella Burnetii nine mile phase II Genome sequencing and assembly

| PRJNA514426 | ENA

Coxiella Burnetii - Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii

Project description:Coxiella Burnetii Nine Mile vs Nine Mile resistant to levofloxacine

2012-07-20 | PRD000262 | Pride

Comparative genomic hybridization of 25 Coxiella burnetii isolates relative to the Nine Mile (RSA493) reference isolate

Project description:Analysis of genetic diversity of 25 Coxiella burnetii isolates with relative to the Nine Mile (RSA493) reference isolate.

2006-10-30 | E-TABM-35 | biostudies-arrayexpress

Coxiella burnetii

Project description:Causes Q-fever

| PRJNA16724 | ENA

Coxiella burnetii RSA 493

Project description:Coxiella burnetii RSA 493 Transcriptome or Gene expression

| PRJNA245835 | ENA

Coxiella burnetii Dugway 5J108-111

Project description:Causes Q fever

| PRJNA16721 | ENA

Macrophage infectivity potentiator protein, a peptidyl prolyl cis/trans isomerase, essential for Coxiella burnetii growth and pathogenesis

Project description:Coxiella burnetii is a Gram-negative intracellular pathogen that causes the debilitating disease Q fever, which affects both animals and humans. The only available vaccine, Q-Vax, is effective but has a high risk of severe adverse reactions, limiting its use as a countermeasure to contain outbreaks. Therefore, it is essential to identify new drug targets to treat this infection. Macrophage infectivity potentiator (Mip) proteins catalyze the folding of proline-containing proteins through their peptidyl prolyl cis-trans isomerase (PPIase) activity and have been shown to play an important role in the virulence of several pathogenic bacteria but to date its role in C. burnetii pathogenesis has not been investigated. This study demonstrates that CbMip is likely to be an essential protein in C. burnetii. Pipecolic acid derived compounds, SF235 and AN296 demonstrate inhibitory activities against CbMip and these compounds were found to significantly inhibit intracellular replication of C. burnetii in both HeLa and THP-1 cells. Furthermore, SF235 and AN296 were also found to exhibit antibiotic properties against both the virulent (Phase I) and avirulent (Phase II) forms of C. burnetii Nine Mile Strain RSA439 in axenic culture with comparative proteomic demonstrating selective alterations in response to these agents. This study also showed that exposure of C. burnetii to Mip inhibitors resulted in increased sensitivity to oxidative stress. Furthermore, compounds SF235 and AN296 demonstrated protective activity in vivo and significantly improved the survival of Galleria mellonella infected with C. burnetii. These results suggest that unlike in other bacteria, Mip in C. burnetii is required for growth and replication and that inhibitors against CbMip offer potential as novel therapeutics against C. burnetii.

2023-06-15 | PXD036679 | Pride

Coxiella burnetii CbuK_Q154

Project description:Causative agent of Q fever

| PRJNA19139 | ENA

Coxiella burnetii

Project description:Host cell-free growth of the Q fever bacterium Coxiella burnetii

| PRJNA109859 | ENA